Exclusion of Known Protease Activated Receptors in Factor VIIa-induced Signal Transduction

Summary

The protease activity is mandatory for intracellular activities induced by coagulation factor VIIa (FVIIa), and in this way it resembles signal transduction induced by thrombin and trypsin caused by specific, proteolytic cleavage of protease activated receptors (PARs). The mechanism for FVIIa-induced signal transduction is, however, not known although a mechanism involving PAR cleavage has been deduced from studies of cytosolic Ca²⁺ release and p44/p42 mitogen activated protein kinase (MAPK) activation. In the present work we have examined the possibilities that i) FVIIa-induced signal transduction involves the activation of one of the four known PARs, or ii) exposure of cells to FVIIa releases a soluble ligand that is responsible for MAPK activation. For this purpose, we evaluated the effects of FVIIa, thrombin, FXa, trypsin and PAR agonist peptides on the Ca²⁺ release and MAPK activation in tissue factor-(TF) transfected baby hamster kidney (BHK[+TF]) cells and Madin-Darby canine kidney (MDCK) cells. FVIIa induced a significant MAPK signal in BHK(+TF) cells and in MDCK-I and -II cells whereas no MAPK activation was observed with thrombin, FXa or PAR agonist peptides. Thrombin, trypsin, PAR-1 and PAR-2 agonist peptides induced a prominent Ca²⁺ response in both cell types. In contrast the cells did not respond with a detectable Ca²⁺ signal when treated with FVIIa. These results suggest that the intracellular activity induced by FVIIa is distinctly different from that induced by trypsin, thrombin and FXa not involving any of the known PARs. Conditioned medium from BHK(+TF) cells treated with FVIIa failed to induce a MAPK response in untreated BHK(+TF) cells when FVIIa was removed by immunoadsorption from the medium prior to its transfer to the untreated BHK(+TF) cells. Although it is not possible entirely to exclude a transient response close to the cell surface, the data suggest that the intracellular response was not induced by an autocrine release of a soluble mediator to the medium.

Keywords

Factor VII - tissue factor - signal transduction - protease activated receptor - cytosolic Ca²⁺ mobilisation

• References

• 1 Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
• 2 Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J, Van Obberghen-Schilling E. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca²⁺ mobilization. FEBS Lett 1991; 288: 123-8.
• 3 Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994; 91: 9208-12.
• 4 Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6.
• 5 Xu W-F, Andersen H, Whitmore TE, Gilbert T, Ching A, Davie EW, Foster DC. Cloning and characterization of protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6.
• 6 Kahn ML, Zheng Y-W, Huang W, Bigornia V, Zeng D, Moff S, Farese Jr RV, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
• 7 Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombinreceptor activation. Biochem. J 1996; 313: 353-68.
• 8 Vouret-Craviari V, van Obbergen-Schilling E, Scimera JC, van Oppergen E, Pouyssegur J. Differential activation of p44MAPK (ERK1) by alphathrombin and thrombin-receptor peptide agonist. Biochem J 1993; 289: 209-14.
• 9 Papkoff J, Chen RH, Blenis J, Forsman J. P42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 1994; 14: 463-72.
• 10 Belham CM, Tate RJ, Scott PH, Pemberton AD, Miller HRP, Wadsworth RM, Gould GW, Plevin R. Trypsin stimulates proteinase-activated receptor-2 dependent and -independent activation of mitogen-activated protein kinases. Biochem J 1996; 320: 939-46.
• 11 Røttingen J-A, Enden T, Camerer E, Iversen J-G, Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca²⁺ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 1995; 270: 4650-60.
• 12 Camerer E, Røttingen J-A, Iversen J-G, Prydz H. Coagulation factors VII and X induce Ca²⁺ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 1996; 271: 29034-42.
• 13 Poulsen LK, Jacobsen N, Sørensen BB, Bergenhem NCH, Kelly JD, Foster DC, Thastrup O, Ezban M, Petersen LC. Signal transduction in the mitogen-activated protein kinase pathway induced by binding of factor VIIa to tissue factor. J Biol Chem 1998; 273: 6228-32.
• 14 Sørensen BB, Freskgård P-O, Nielsen LS, Rao LVM, Ezban M, Petersen LC. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999; 274: 21349-54.
• 15 Thim L, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-93.
• 16 Sørensen BB, Persson E, Freskgård P-O, Kjalke M, Ezban M, Williams T, Rao LVM. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem 1997; 272: 11863-8.
• 17 Freskgård P-O, Olsen OH, Persson E. Structural changes in factor VIIa induced by Ca²⁺ and tissue factor studied using circular dichroism spectroscopy. Protein Science 1996; 05: 1531-40.
• 18 Busby SJ, Mulvihill E, Rao D, Kumar AA, Lioubin P, Heipel M, Sprecher C, Halfpap L, Prunkard D, Gambee J, Foster DC. Expression of recombinant human plasminogen in mammalian cells is augmented by suppression of plasmin activity. J Biol Chem 1991; 266: 15286-92.
• 19 Gorman CM. In: DNA cloning. A practical approach vol. 1-2. Glover DM. Oxford IRL Press; 1985: 142-65.
• 20 Røttingen J-A, Camerer E, Mathiesen J, Prydz H, Iversen J-G. Syncronized Ca²⁺oscillations induced in Madin Darby canine kidney cells by bradykinin and thrombin but not by ATP. Cell Calcium 1997; 21: 195-211.
• 21 Molino M, Woolkalis MJ, Reavey-Cantwell J, Pratico D, Anrade-Gordon P, Barnathan ES, Brass LF. Endothelial Cell thrombin receptors and PAR-2; Two protease-activated receptors located in a single cellular environment. J Biol Chem 1997; 272: 11133-41.
• 22 Fox MT, Harriott P, Walker B, Stone SR. Identification of potential activators of proteinase-activated receptor-2. FEBS Lett 1997; 417: 267-9.
• 23 Schaeffer P, Mares A-M, Dol F, Bono F, Herbert J-M. Coagulation factor Xa induces endothelium-dependent relaxations in rat aorta. Circulation Res 1997; 81: 824-8.
• 24 Molloy C, Pawlowski JE, Taylor DS, Turner CE, Weber H, Peluso M. Thrombin receptor activation elicts rapid protein tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured aortic smooth muscle cells. J Clin Invest 1996; 97: 1173-83.
• 25 Ko FN, Yang YC, Huang SC, Ou JT. Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest 1996; 98: 1493-501.
• 26 Herbert J-M, Bono F, Herault J-P, Avril C, Dol F, Mares A-M, Schaeffer P. Effector protease Receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest 1998; 101: 993-1000.